MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
The IL-17 family cytokines IL-17A and IL-17C drive the pathogenesis of psoriatic skin inflammation, and anti–IL-17A Abs were recently approved to treat human psoriasis. Little is known about mechanisms that restrain IL-17 cytokine-mediated signaling, particularly IL-17C. In this article, we show that the endoribonuclease MCP-1–induced protein 1 (MCPIP1; also known as regnase-1) is markedly upregulated in human psoriatic skin lesions. Similarly, MCPIP1 was overexpressed in the imiquimod (IMQ)-driven mouse model of cutaneous inflammation. Mice with an MCPIP1 deficiency (Zc3h12a+/−) displayed no baseline skin inflammation, but they showed exacerbated pathology following IMQ treatment. Pathology in Zc3h12a+/− mice was associated with elevated expression of IL-17A– and IL-17C–dependent genes, as well as with increased accumulation of neutrophils in skin. However, IL-17A and IL-17C expression was unaltered, suggesting that the increased inflammation in Zc3h12a+/− mice was due to enhanced downstream IL-17R signaling. Radiation chimeras demonstrated that MCPIP1 in nonhematopoietic cells is responsible for controlling skin pathology. Moreover, Zc3h12a+/−Il17ra−/− mice given IMQ showed almost no disease. To identify which IL-17RA ligand was essential, Zc3h12a+/−Il17a−/− and Zc3h12a+/−Il17c−/− mice were given IMQ; these mice had reduced but not fully abrogated pathology, indicating that MCPIP1 inhibits IL-17A and IL-17C signaling. Confirming this hypothesis, Zc3h12a−/− keratinocytes showed increased responsiveness to IL-17A and IL-17C stimulation. Thus, MCPIP1 is a potent negative regulator of psoriatic skin inflammation through IL-17A and IL-17C. Moreover, to our knowledge, MCPIP1 is the first described negative regulator of IL-17C signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this is concomitant with exacerbated autoimmunity in models of EAE and imiquimod-psoriasis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Monin et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In humans, Regnase-1 expression is elevated in psoriatic lesions and other conditions of IL-17-driven inflammation”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Monin et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas beneficial IL-17 signaling is enhanced in Regnase-1-deficient mouse settings, as demonstrated by heightened resistance to fungal infection”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Monin et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 1×
“stimulated with IL-17A upregulate antimicrobial peptides and neutrophil-attracting chemokines (43, 44).”
BackgroundImiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
van der Fits, L., Mourits, S., Voerman, J. S. A., Kant, M., Boon, L., Laman, J. D., Cornelissen, F., Mus, A.-M., Florencia, E., Prens, E. P., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802999 · Cited by 2,176 · cited 3×
“In the IMQ dermatitis model, IL-17RA–deficient mice show dramatically reduced disease development (31).”
BackgroundDevelopment, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 1×
“I n the past decade, IL-17 family members have emerged as drivers of inflammatory and autoimmune conditions, particularly psoriasis (1).”
BackgroundSelf-citationInnate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
Cargill, M., Schrodi, S. J., Chang, M., Garcia, V. E., Brandon, R., Callis, K. P., Matsunami, N., Ardlie, K. G., Civello, D., Catanese, J. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/511051 · Cited by 1,086
TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes
Kronenberg, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115742 · Cited by 1,029
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Baeten, D., Sieper, J., Braun, J., Baraliakos, X., Dougados, M., Emery, P., Deodhar, A., Porter, B., Martin, R., Andersson, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505066 · Cited by 1,029
Research works printed but not linked: 2
- Gaffen SL Jain R Garg A Cua D 2014 IL-23-IL-17 immune axis: From mechanisms to therapeutic testing Nat Rev Immunol 14 585 600 25145755 PMC4281037
- Matsushita K Takeuchi O Standley DM Kumagai Y Kawagoe T Miyake T Satoh T Kato H Tsujimura T Nakamura H Akira S 2009 Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay Nature 458 1185 1190 19322177
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“In humans, Regnase-1 expression is elevated in psoriatic lesions and other conditions of IL-17-driven inflammation, indicating that its activity can be offset in inflammatory environments (Monin et al., 2017).”
BackgroundSelf-citationIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“while exacerbating IL-17-mediated pathology in mouse models of EAE, pulmonary inflammation and psoriasis [74, 95].”
BackgroundSelf-citationIL-17 receptor–based signaling and implications for disease
Li, X., Bechara, R., Zhao, J., McGeachy, M. J., & Gaffen, S. L. (2019) · Nature Immunology · doi:10.1038/s41590-019-0514-y · Cited by 548
Self-citationThe IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
“In addition, IL-17C is upregulated in murine psoriasiform dermatitis (62, 92, 93), and IL-17C-deficient mice develop milder skin inflammation upon imiquimod application (96, 98).”
BackgroundMonin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
“We recently showed that the action of MCPIP1 can also curb IL-17C-mediated inflammation in murine keratinocytes both in vitro and in vivo, thereby limiting skin inflammation in the imiquimod-driven psoriasis model (Monin et al. 2017).”
BackgroundSelf-citationRNA-binding proteins control gene expression and cell fate in the immune system
Turner, M., & Díaz-Muñoz, M. D. (2018) · Nature Immunology · doi:10.1038/s41590-017-0028-4 · Cited by 209
The metabolism-modulating activity of IL-17 signaling in health and disease
Bechara, R., McGeachy, M. J., & Gaffen, S. L. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20202191 · Cited by 104
Self-citationIL-17C/IL-17RE: Emergence of a Unique Axis in TH17 Biology
Nies, J. F., & Panzer, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00341 · Cited by 104
Arid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity
Nyati, K. K., Zaman, M. M.-U., Sharma, P., & Kishimoto, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.01.004 · Cited by 93
Control of RNA Stability in Immunity
Akira, S., & Maeda, K. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101819-075147 · Cited by 92
Amatya, N., Childs, E. E., Cruz, J. A., Aggor, F. E. Y., Garg, A. V., Berman, A. J., Gudjonsson, J. E., Atasoy, U., & Gaffen, S. L. (2018) · Science Signaling · doi:10.1126/scisignal.aat4617 · Cited by 75
Self-citationIL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation
Floudas, A., Saunders, S. P., Moran, T., Schwartz, C., Hams, E., Fitzgerald, D. C., Johnston, J. A., Ogg, G. S., McKenzie, A. N., Walsh, P. T., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602185 · Cited by 69
Post-transcriptional regulation of immune responses by RNA binding proteins
Mino, T., & Takeuchi, O. (2018) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.94.017 · Cited by 78
Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response
Tanaka, H., Arima, Y., Kamimura, D., Tanaka, Y., Takahashi, N., Uehata, T., Maeda, K., Satoh, T., Murakami, M., & Akira, S. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181078 · Cited by 79
Regulation of mRNA stability by CCCH-type zinc-finger proteins in immune cells
Maeda, K., & Akira, S. (2017) · International Immunology · doi:10.1093/intimm/dxx015 · Cited by 64
Current understanding of the role of tyrosine kinase 2 signaling in immune responses
Muromoto, R., Oritani, K., & Matsuda, T. (2022) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v13.i1.1 · Cited by 68
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1
Nakatsuka, Y., Yaku, A., Handa, T., Vandenbon, A., Hikichi, Y., Motomura, Y., Sato, A., Yoshinaga, M., Tanizawa, K., Watanabe, K., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00018-2020 · Cited by 56
Roles of RNA-binding proteins in immune diseases and cancer
Hashimoto, S., & Kishimoto, T. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.017 · Cited by 53
Psoriasis: Past, Present, and Future
Billi, A. C., Gudjonsson, J. E., & Voorhees, J. J. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.08.437 · Cited by 55
Self-citationTakaishi, M., Satoh, T., Akira, S., & Sano, S. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.12.033 · Cited by 41
Substrate specificity of human MCPIP1 endoribonuclease
Wilamowski, M., Górecki, A., Dziedzicka‐Wasylewska, M., & Jura, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-25765-2 · Cited by 35
RNA binding proteins in the control of autoimmune diseases
Yoshinaga, M., & Takeuchi, O. (2019) · Immunological Medicine · doi:10.1080/25785826.2019.1655192 · Cited by 38
“albicans infection, increased susceptibility to EAE and imiquimod-induced psoriasis [66,67] T-cell-specific deletion: Lymphadenopathy, splenomegaly and the production of autoantibodies [62] IEC-specific deletion: Iron deficiency anemia [64] Regnase-4 Unknown Unknown IL2, IL6, IL10, IL17, and TNF Global deletion: Incre…”
BackgroundTakeuchi, O. (2017) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1449 · Cited by 37
“This model is dependent on IL-17A and IL-17C.45 The report showed that the IL-17A- and IL-17Cassociated genes were highly enhanced in Regnase- 1+/− mice, whereas the expression of IL-17A and IL-17C was unaltered.”
BackgroundRegnase-1 degradation is crucial for IL-33– and IL-25–mediated ILC2 activation
Matsushita, K., Tanaka, H., Yasuda, K., Adachi, T., Fukuoka, A., Akasaki, S., Koida, A., Kuroda, E., Akira, S., & Yoshimoto, T. (2020) · JCI Insight · doi:10.1172/jci.insight.131480 · Cited by 33
“17 Regnase-1 is also involved in IL-17–induced immune responses (32, 33, 53).”
BackgroundPost‐transcriptional control of immune responses and its potential application
Yoshinaga, M., & Takeuchi, O. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1063 · Cited by 33
“The signal transduction of the IL-17 receptor is reportedly regulated by Regnase-1 in the disease model of psoriasis.(62,63) Regnase-1 was shown to be upregulated in psoriatic skin lesions in the imiquimod-treated mouse model and human patients.”
BackgroundIL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis
Dhamija, B., Marathe, S., Sawant, V., Basu, M., Attrish, D., Mukherjee, D., Kumar, S., Pai, M. G. J., Wad, S., Sawant, A. D., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300319 · Cited by 32
Konieczny, P., Lichawska-Cieślar, A., Kwiecińska, P., Cichy, J., Pietrzycka, R., Szukała, W., Declercq, W., Devos, M., Paziewska, A., Rumieńczyk, I., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01853-2 · Cited by 29
MCPIP1 RNase and Its Multifaceted Role
Musson, R., Szukała, W., & Jura, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197183 · Cited by 29
“MCPIP1 is induced by IL-17A dependent on STAT3 phosphorylation [87] and appears to inhibit IL-17A and IL-17C signalling because Zc3h12a−/− keratinocytes exhibit increased inflammatory responsiveness to IL-17A and IL-17C stimulation [88].”
BackgroundInfluentialRegnase‐1–related endoribonucleases in health and immunological diseases
Mino, T., & Takeuchi, O. (2021) · Immunological Reviews · doi:10.1111/imr.13023 · Cited by 35
Nakatsuka, Y., Vandenbon, A., Mino, T., Yoshinaga, M., Uehata, T., Cui, X., Sato, A., Tsujimura, T., Suzuki, Y., Sato, A., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0024-5 · Cited by 31
IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization
Muromoto, R., Tawa, K., Ohgakiuchi, Y., Sato, A., Saino, Y., Hirashima, K., Minoguchi, H., Kitai, Y., Kashiwakura, J., Shimoda, K., et al. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900023 · Cited by 27
Gou, C., Ni, W., Ma, P., Zhao, F., Wang, Z., Sun, R., Wu, Y. C., Wu, Y., Chen, M., Chen, H., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03774-w · Cited by 26
Habacher, C., & Ciosk, R. (2017) · BioEssays · doi:10.1002/bies.201700051 · Cited by 30
“In this context, Regnase-1, whose levels increase in psoriatic skin, mitigates inflammation-promoting effects of IL-17A and IL-17C [21, 44].”
BackgroundTse, K. M., Vandenbon, A., Cui, X., Mino, T., Uehata, T., Yasuda, K., Sato, A., Tsujimura, T., Hia, F., Yoshinaga, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2137 · Cited by 31
Xu, Y., Liang, J., Gao, W., Sun, Y., Zhang, Y., Shan, F., Ge, J., & Xia, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1021309 · Cited by 28
“Prior studies showed a crucial role of IL-17C in the pathogenesis of immune-mediated skin diseases (37), autoimmune hepatitis (38), and acute pneumonia (39).”
Background14-3-3ζ–TRAF5 axis governs interleukin-17A signaling
McGowan, J., Peter, C., Kim, J. P., Popli, S., Veerman, B., Saul‐McBeth, J., Conti, H. R., Pruett‐Miller, S. M., Chattopadhyay, S., & Chakravarti, R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008214117 · Cited by 24
Regulation of inflammatory diseases via the control of mRNA decay
Yoshinaga, M., & Takeuchi, O. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00326-5 · Cited by 23
“Also, in the skin, Regnase-1 in keratinocytes suppresses IL-17R signaling, thus inhibiting psoriasis development [117].”
BackgroundPost-transcriptional checkpoints in autoimmunity
Bechara, R., Vagner, S., & Mariette, X. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00980-y · Cited by 25
Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
Szukała, W., Lichawska-Cieślar, A., Pietrzycka, R., Kulecka, M., Rumieńczyk, I., Mikuła, M., Chlebicka, I., Konieczny, P., Dziedzic, K., Szepietowski, J. C., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02202-3 · Cited by 19
Zhu, L., Liao, S. E., & Fukunaga, R. (2019) · RNA Biology · doi:10.1080/15476286.2019.1630799 · Cited by 22
How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?
Xu, R., Li, Y., Liu, Y., Qu, J., Cao, W., Zhang, E., He, J., & Cai, Z. (2020) · Protein & Cell · doi:10.1007/s13238-020-00739-1 · Cited by 19
MCPIP1 regulates the sensitivity of pancreatic beta-cells to cytokine toxicity
Tyka, K., Jörns, A., Turatsinze, J., Eizirik, D. L., Lenzen, S., & Gurgul-Convey, E. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1268-4 · Cited by 18
Jiang, Y., Gruszka, D., Zeng, C., Swindell, W. R., Gaskill, C. F., Sorensen, C., Brown, W., Gangwar, R. S., Tsoi, L. C., Webster, J., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.172764 · Cited by 20
“ZC3H12A/Regnase-1 has been previously shown to suppress imiquimod-elicited skin inflammation by regulating IL-17A and IL-17C responses (20).”
BackgroundSelf-citationMCPIP1 contributes to the inflammatory response of UVB-treated keratinocytes
Bugara, B., Konieczny, P., Wolnicka-Głubisz, A., Eckhart, L., Fischer, H., Skalniak, Ł., Borowczyk, J., Drukała, J., & Jura, J. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.03.013 · Cited by 17
The RNA binding protein Arid5a drives IL-17–dependent autoantibody-induced glomerulonephritis
Li, Y., Vyas, S., Mehta, I. D., Asada, N., Dey, I., Taylor, T. C., Bechara, R., Amatya, N., Aggor, F. E. Y., Coleman, B. M., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20240656 · Cited by 15
“The endoribonuclease Regnase-1 ( Zc3h12a ) is a feedback inhibitor of IL-17 signaling and Th17 cell differentiation in several autoimmune settings including AGN (Behrens et al., 2018, 2021; Garg et al., 2015; Jeltsch et al., 2014; Li et al., 2021; Monin et al., 2017).”
InfluentialSelf-citationRoquin-dependent gene regulation in immune-mediated diseases and future therapies
Raj, T., Negraschus, A., & Heissmeyer, V. (2022) · International Immunology · doi:10.1093/intimm/dxac059 · Cited by 15
Regnase-1 Is an Endoribonuclease Essential for the Maintenance of Immune Homeostasis
Uehata, T., & Takeuchi, O. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2017.0001 · Cited by 14
Chen, X., Zhao, Q., Xie, Q., Xing, Y., & Chen, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.083 · Cited by 12
Li, D., Bechara, R., Ramani, K., Jawale, C. V., Li, Y., Kolls, J. K., Gaffen, S. L., & Biswas, P. S. (2021) · JCI Insight · doi:10.1172/jci.insight.147505 · Cited by 12
“In CD4 + T cells, loss of Regnase-1 leads to markedly elevated IL-6 levels and, consequently, elevated Th17 differentiation and exacerbated autoimmune disease, demonstrated in the experimental autoimmune encephalitis (EAE) model of multiple sclerosis (35).”
InfluentialSelf-citationVenz, R., Goyala, A., Soto-Gamez, A., Yenice, T., Demaria, M., & Ewald, C. Y. (2023) · GeroScience · doi:10.1007/s11357-023-00909-z · Cited by 14
p38 but not p53 is responsible for UVA-induced MCPIP1 expression
Skalniak, Ł., Smejda, M., Cierniak, A., Adamczyk, A., Konieczny, P., Madej, E., & Wolnicka-Głubisz, A. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.11.008 · Cited by 11
“and Kolattukudy, 2009), psoriasis (Monin et al., 2017), HIV infection (Liu et al.”
BackgroundTrevejo-Nuñez, G., Lin, B., Fan, L., Aggor, F. E. Y., Biswas, P. S., Chen, K., & Gaffen, S. L. (2022) · mBio · doi:10.1128/mbio.03792-21 · Cited by 11
“ing that Reg1 functions in these settings through restricting IL-17-driven inflammation (11, 15, 16).”
BackgroundMethodSelf-citationAn, Q., Xia, J., Pu, F., & Shi, S. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13129 · Cited by 11
“…biological roles in lipid homeostasis (30), insulin secretion (31) and the inflammatory response (32), and also regulates the development of certain diseases, such as hidradenitis suppurativa (33), primary biliary cholangitis (34), skin inflammation (35) and clear cell renal cell carcinoma (36).”
BackgroundYang, G., Lee, H., Trzeciak, M., Pawełczyk, T., Takeuchi, O., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114558 · Cited by 10
Lichawska-Cieślar, A., Konieczny, P., Szukała, W., Declercq, W., Fu, M., & Jura, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118866 · Cited by 11
“In particular, heterozygous Mcpip1−/+ mice developed IMQ-induced psoriasiform inflammation faster than control mice [6].”
BackgroundInfluentialRNA-binding proteins and ribonucleoproteins as determinants of immunity
Turner, M., & Petkau, G. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-025-01254-2 · Cited by 13
Morisaka, H., Takaishi, M., Akira, S., & Sano, S. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.11.007 · Cited by 8
Immune regulation mechanism of vitamin�D level and IL‑17/IL‑17R pathway in Crohn's disease
Xia, Y., Chen, H., Xiao, H., Yang, J., Li, Z., Wang, Y., Yang, T., & Wang, B. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7389 · Cited by 8
“It is hypothesized that vitamin D may exert its therapeutic effects on Crohn's disease by acting on IL-17/IL-17R pathway.”
BackgroundInfluentialWang, Y., Li, C., Zhang, T., Wang, J., Liu, W., Deng, L., Jiang, Y., Duan, J., Wang, L., Ge, H., et al. (2025) · View · doi:10.1002/viw.20240145 · Cited by 11
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge
Ruggiero, A., Megna, M., Fabbrocini, G., Fornaro, L., & Villani, A. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2134855 · Cited by 7
Szukała, W., Pilarczyk-Żurek, M., Folkert, J., Kotlinowski, J., Kozieł, J., & Jura, J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166764 · Cited by 7
RNA Metabolism Governs Immune Function and Response
Yoshinaga, M., & Takeuchi, O. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-9781-7_10 · Cited by 6
Multifunctional RNase MCPIP1 and its Role in Cardiovascular Diseases
Yan, B., Guo, Y., Gui, Y., Jiang, Z., & Zheng, X. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327999201113100918 · Cited by 5
Krajewski, P. K., Szukała, W., Lichawska-Cieślar, A., Matusiak, Ł., Jura, J., & Szepietowski, J. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147241 · Cited by 5
“[23] demonstrated MCPIP1 expression distributed in the whole epidermis of the healthy skin.”
BackgroundResultInfluentialSystemic MCPIP1 deficiency in mice impairs lipid homeostasis
Moody, J. D., Yang, C., Sedinkin, J. D., & Chang, Y. (2020) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2020.03.001 · Cited by 3
The RNA binding protein Arid5a is an activator of TNF signaling in rheumatoid arthritis
Li, Y., Dey, I., Vyas, S., Synackova, A., Decheng, L. I., Lubberts, E., Ascherman, D. P., Dráber, P., & Gaffen, S. L. (2026) · JCI Insight · doi:10.1172/jci.insight.196411 · Cited by 3
“Despite suppressive functions that constrain cytokine-induced inflammation, Regnase-1 is often elevated in autoimmunity, as observed in psoriatic skin and demonstrated here in blood from patients with RA (64–66).”
Self-citationThe tissue-specific regulation of immunobiology by IL-17 signaling
Li, Y., Vyas, S., Dráber, P., Bechara, R., & Gaffen, S. L. (2026) · Science Immunology · doi:10.1126/sciimmunol.adq6406 · Cited by 2
Self-citationMCPIP3 orchestrates the balance of epidermal proliferation and differentiation
Lichawska-Cieślar, A., Szukała, W., Pilat, P., Eckhart, L., Szepietowski, J. C., & Jura, J. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02184-1 · Cited by 3
“…investigated the role of MCPIP1 RNase in the skin and demonstrated that its activity is mostly important for the regulation of skin immunity [17, 19–21 , Our studies utilizing NHEKs revealed that the expression of MCPIP1 and MCPIP3 is differentially modulated during in vitro differentiation and…”
Li, D., Bechara, R., Ramani, K., Jawale, C. V., Li, Y., Kolls, J. K., Gaffen, S. L., & Biswas, P. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.11.425972 · Cited by 2
“In CD4+ T cells, loss of Regnase-1 leads to markedly elevated IL-6 levels, and consequently, elevated Th17 differentiation and exacerbated autoimmune disease, demonstrated in the experimental autoimmune encephalitis (EAE) model of multiple sclerosis (35).”
BackgroundSelf-citationKim, S. W., Lee, K., Lee, J. Y., Jang, J. Y., & Yang, G. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.055 · Cited by 2
Regnase-1-mediated regulation of neutrophils modulates SARS-CoV-2 pneumonia
Yasuda, K., Aoki, J., Tanaka, K., Shichinohe, S., Ono, C., Vandenbon, A., Ohara, D., Muramoto, Y., Li, S., Motooka, D., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013969 · Cited by 1
The Regnase pathway: a core axis in immune regulation and inflammatory disease
Muzio, L., Ferrati, D., Colombo, E., & Molinaro, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1756491 · Cited by 4
Deng, J., Liu, Q., Liu, W. T., He, Z., He, W., Yao, D., & Chen, X. (2026) · 3 Biotech · doi:10.1007/s13205-025-04682-y · Cited by 1
“The IGV analysis revealed significant alter - ations in histone lactylation levels for genes (such as Akt2, Ano6, Tmem30a, Fzd4, Osbpl8, Ppard, Soat1, Zfyve1, and Zc3h12a) associated with lipid transport and storage processes in the IMQ + TQC group, which stood in stark contrast to the patterns observed in the IMQ gro…”
Associations between vaginal flora, MIP‐1α, IL‐17A, and clinical pregnancy rate in AIH
Yang, H., Gao, C., Wang, X., Qiu, F., Wei, M., & Xia, F. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13543 · Cited by 1
Li, Y., Cai, J., & Chong, H. (2024) · Research Square · doi:10.21203/rs.3.rs-3758249/v1
Additional file 5 of Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
Szukała, W., Lichawska-Cieślar, A., Pietrzycka, R., Kulecka, M., Rumieńczyk, I., Mikula, M., Chlebicka, I., Konieczny, P., Dziedzic, K., Szepietowski, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17194042
Additional file 3 of Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
Szukała, W., Lichawska-Cieślar, A., Pietrzycka, R., Kulecka, M., Rumieńczyk, I., Mikula, M., Chlebicka, I., Konieczny, P., Dziedzic, K., Szepietowski, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17194036
Additional file 2 of Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
Szukała, W., Lichawska-Cieślar, A., Pietrzycka, R., Kulecka, M., Rumieńczyk, I., Mikula, M., Chlebicka, I., Konieczny, P., Dziedzic, K., Szepietowski, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17194030
Additional file 1 of Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
Szukała, W., Lichawska-Cieślar, A., Pietrzycka, R., Kulecka, M., Rumieńczyk, I., Mikula, M., Chlebicka, I., Konieczny, P., Dziedzic, K., Szepietowski, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17194021
Additional file 4 of Loss of epidermal MCPIP1 is associated with aggressive squamous cell carcinoma
Szukała, W., Lichawska-Cieślar, A., Pietrzycka, R., Kulecka, M., Rumieńczyk, I., Mikula, M., Chlebicka, I., Konieczny, P., Dziedzic, K., Szepietowski, J. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.17194039
The Role of Regnase-1 in Autoimmune Diseases – A Future Therapeutic Target for Clinical Use
Wang, M., Huang, Z., Gong, X., Rui, K., Tian, J., & Liu, M. (2026) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-026-09156-4
Li, Y., Liu, Y., Su, Y., Wang, Y., & Wang, X. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12852-1
Metadata
- Authors
- Monin, L., Gudjonsson, J. E., Childs, E. E., Amatya, N., Xing, X., Verma, A. H., Coleman, B. M., Garg, A. V., Killeen, M., Mathers, A., Ward, N. L., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- University of Michigan (US)
- Case Western Reserve University (US)
- Corresponding author
- Monin, Leticia
- Amatya, Nilesh
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01
- Volume
- 198
- Issue
- 2
- Pages
- 767-775
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC5225040
- OpenAlex
- W2560803412
- Cited by
- 82
- References
- 69
- Citations by year
- 2026: 8 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 9 · 2021: 13 · 2020: 10 · 2019: 11 · 2018: 7 · 2017: 10
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- National Institutes of Health (5r37de022550-12)
- Genentech
- National Institute of Allergy and Infectious Diseases (R01AI107825)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR039750, R01AR066548, R21AR063852, R01AR062546, R01AR063437, R01AR069071, R01AR067746)
- National Institute of Dental and Craniofacial Research (R37-DE022550, R01DE022550)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- MCPIP1, Regnase-1, ZC3H12A, IL-17A, IL-17C, psoriasis, IL-17 receptor signaling, imiquimod-induced skin inflammation, keratinocytes, neutrophil accumulation, endoribonuclease, negative regulation of cytokine signaling
- MeSH terms
- Animals, Dermatitis, Flow Cytometry, Humans, Immunohistochemistry, Psoriasis, Ribonucleases, Transcription Factors, Keratinocytes, Mice, Knockout, Interleukin-17, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.